about
Emerging drugs for the treatment of tobacco dependence: 2014 updateVarenicline as a Cause of Suicidal OutcomesVarenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort studyVarenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trialStudy results from the Clinical Trials Network's first 10 years: where do they lead?Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in CaucasiansThe safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study.Improved patient outcome with smoking cessation: when is it too late?Pharmacologic agents for smoking cessation: a clinical review.Gender difference and effect of pharmacotherapy: findings from a smoking cessation service.Varenicline-induced psychotic depressive episode in a patient with bipolar disorder.Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors.Varenicline use in patients with mental illness: an update of the evidence.Pre-operative pulmonary assessment for patients with hip fracture.Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction?Designation of obesity as a disease: lessons learned from alcohol and tobacco.Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis.Seven-day continuous abstinence rate from smoking at 1, 2, or 3 years after the use of varenicline.The role of second-hand smoke exposure on smoking cessation in non-tobacco-related cancers.The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine.The cessation and detoxification effect of tea filters on cigarette smoke.Evaluation of the cardiovascular effects of varenicline in rats.Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study.Cost-effectiveness of varenicline for smoking cessation.Moving forward in smoking cessation: issues for psychiatric nurses.Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand.An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine binding protein.Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo.
P2860
Q28236453-5FA0C53B-EB5F-44DF-9C0A-D3D1ABA04C18Q28255130-F7F980B8-7155-45C1-B380-9026ABFBFAE6Q28646213-AE9D3E25-94D2-4B3C-A808-3D87DB245A29Q33508060-BF0F286D-1922-445D-84ED-6BE0AF28050BQ33897433-8FB70A20-B8FF-42FA-9F84-E64C6BDD52B2Q34018862-71B26340-14C9-4D1D-96A1-874F0EC7AAA8Q34075548-F8EB5674-E3D6-4ED4-B534-C19CB1911A1AQ34255450-0170F56C-2EB9-4D58-8E1A-494D4DA76DE2Q35131482-CF69391D-42D1-4D92-A680-2506ADB19D31Q35683916-67AC0918-2D44-4B59-AE9B-0CA4F1660DC8Q36157191-23FEBBF7-DF09-4FC9-9C54-937445ABEA44Q37079004-94539595-6277-480A-ADC1-6A4008079E4FQ37485527-B28C4EBC-F553-48F1-BA38-1F5802F52C78Q37637054-7BB13377-302D-4E82-9C95-A46EFABDE19CQ37694553-E31E7589-688B-4A27-846C-2E6C739C78BEQ37807916-633B9CDF-D4B2-4BB7-80AA-D5371FC49F1EQ37868003-74813F7B-5200-4064-AF6A-179C8273D836Q38031894-57A503AB-C435-4E55-90B4-05D7987B5C1CQ38129470-74CA8AFA-D4B7-497A-ADCF-F5AB6B56B660Q38256181-F986395D-B254-4A28-BA69-2E04CA5C4653Q38797685-7521B35D-65CE-4826-BBB4-F720EB1B8768Q39019456-2EC21B04-A129-45B1-9671-E683E16C3284Q41068538-5DBAD76C-FD0A-4BD9-8139-2D56060071BBQ42627924-B81F6D60-A868-4E81-9D40-D01E7AA032CFQ42992993-D4B92E78-D5F7-42D4-9D44-44A30FA8CBBFQ43200073-45D2D838-F6A1-4B9F-BCD2-71CFE48C72A5Q44960238-FF54B892-3D08-48C3-B3F6-0B75BB6B3FB1Q45909594-B5630ADE-CB1B-4B8E-BAA2-E4238FB91B68Q45968869-E25E2B74-1EC9-485F-8E5C-AE8E38A5C0FAQ45993006-D54623C4-943D-4FA5-8B70-D06DF76C2838Q46561624-037495C8-6EFB-41F6-85CB-B4E2511D04BDQ47296588-88811482-01FF-4BFE-853A-A6FE3CC383D0Q47773172-D3E4F28B-ACB0-4B74-AAC3-E74A1AA161B4
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Varenicline for tobacco dependence.
@ast
Varenicline for tobacco dependence.
@en
Varenicline for tobacco dependence.
@nl
type
label
Varenicline for tobacco dependence.
@ast
Varenicline for tobacco dependence.
@en
Varenicline for tobacco dependence.
@nl
prefLabel
Varenicline for tobacco dependence.
@ast
Varenicline for tobacco dependence.
@en
Varenicline for tobacco dependence.
@nl
P2860
P356
P1476
Varenicline for tobacco dependence.
@en
P2093
J Taylor Hays
Jon O Ebbert
P2860
P304
P356
10.1056/NEJMCT0800146
P407
P577
2008-11-01T00:00:00Z